Drug Invention Today
ISSN NO: 0975-7619
Drug Invention Today (DIT) was first published in 2009 by JPR Solutions. It is a journal, which publishes reviews, research papers and short communications . 
• Novel Drug Delivery Systems • Nanotechnology & Nanomedicine • Biotechnology related pharmaceutical technology • Polymeric bio-conjugates • Biological macromolecules • Biomaterials • Drug Information • Drug discovery/development • Screening of drugs from natural & synthetic origins • Novel therapeutic strategies • Combinatorial chemistry and parallel synthesis • Clinical trials • Case Reports
 Impact FactorTM ( India ) = 0.897 as on date (08.05.2017)
  Scopus Indexed ( link http://www.scimagojr.com/journalsearch.php?q=21100202909&tip=sid&clean=0)
Journal Metrics for this   Drug Invention Today (Source ID: 21100202909): 2014 (SNIP) Source Normalized Impact Per Paper : 0.402; SCImago Journal Rank (SJR):0.301; Impact Per Publication : 0.517 (Top level : Life Science)
Indexed in
NCBI NLM Catalogue,
SCOPUS, EMBASE (Elsevier),
SCIMAGO, CAS,
ROAD, CABI, Google Scholar,
Open J-Gate, Biblioteca,
Science Central,
Index Scholar, Indian Citation Index,
 AYUSH Research Portal, 
Indexed Copernicus, EBSCO, PSOAR,
Ulrichs Directory of Periodicals, etc.
  • Indexing
  • Author Guidelines
  • Copyright Notice
  • Editorial Board
  • 1. http://www.scimagojr.com/journalsearch.php?q=21100202909&tip=sid&clean=0
     
    SCImago Journal & Country Rank
     
    2. http://endnote.com/downloads/style/drug-invention-today
    3. http://publicationethics.org/members/drug-invention-today
    4. https://scholar.google.co.in/citations?user=DvHkMU0AAAAJ&hl=en
    5.http://www.citefactor.org/journal/index/1532/drug-invention-today#.VcYmm3 Gqqko  
    6. http://www.ncbi.nlm.nih.gov/nlmcatalog/101619441
    7. http://journaldir.petra.ac.id/browse_journal2.php?id=17101
    8. http://www.webcitation.org/archive.php (author can freely upload )
    9.http://www.citationmachine.net/drug-invention-today/cite-a-journal/manual (author can freely upload)
    10. http://en.journals.sid.ir/JournalList.aspx?ID=23338
    11. http://ores.su/en/journals/drug-invention-today/
    12. http://pubget.com/journal/0975-7619/drug-invention-today
    13. http://www.journals4free.com/link.jsp?l=17953464
    14. http://library.wur.nl/WebQuery/clc/2032712 
    15. http://trove.nla.gov.au/work/38532528?versionId=51078376
     
      scopus
     
     
  • PREPARATION OF MANUSCRIPTS 
    Manuscripts must be in "Times New Roman" font-size 10, with double spacing. Please arrange the manuscript as follows: Title page, abstract, introduction, methods, results and discussion, and references, tables, figure captions and figures. Number all pages consecutively at the bottom, beginning with the title page. Figures and tables must be cited in the manuscript.
    It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs and not spaces to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts. Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on electronic artwork. To avoid unnecessary errors, you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor. Lines must be numbered consecutively throughout the manuscript and all pages must be numbered.
     
    MANUSCRIPT STRUCTURE
    Subdivision - Numbered Sections: Divide the article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering for internal cross-referencing also: do not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear on its own separate line.
    Introduction: State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
    Material and methods: Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
    Results and discussion: Results should be clear and concise. Discussions should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
    Conclusion: The main conclusions of the study may be presented in a short conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
    Appendices: If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
     
    Title page information
    • Title: Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible. A short running title not exceeding 40 characters must be provided.
    • Author names and affiliations: Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name. The journal reserves the right to ask for the contribution of each author to an article.
    • Corresponding author: Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
    • Present/permanent address: If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
     
    Abstract: A concise and structured abstract is required under the headings like objectives, methods, results, and conclusions. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References and non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. The abstract should not exceed 250 words.
    Graphical abstract: A Graphical abstract is required for this journal. It should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership online. Authors must provide images that clearly represent the work described in the article. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Images should be clear enough and of appropriate size (5 inch × 7 inch or larger) for better reproduction. If scanned, they should be scanned at minimum of 300 dpi. Color images must be CMYK. Line art drawing must have a minimum resolution of 1200 dpi. Permission to reproduce any borrowed image must be obtained from the author and the publisher. Preferred file types: TIFF, and JPEG files.
    Keywords: A maximum of 5 keywords are required after the abstract.
    Acknowledgements: Acknowledgements should be given in a separate section at the end of the article before the references.
    Artwork - Electronic artwork:
    • Make sure you use uniform lettering and sizing of your original artwork.
    • Save text in illustrations as 'graphics' or enclose the font.
    • Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
    • Number the illustrations according to their sequence in the text.
    • Use a logical naming convention for your artwork files.
    • Provide captions to illustrations separately.
    • Produce images near to the desired size of the printed version.
    Submit each figure as a separate Excel file.
    Journal Articles
    1) George JN, Woolf SH, Raskob GE, Wasser JS, Aledrot LM, Ballem PJ. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods of the American Society of Hematology. Blood, 1996, 88, 3–40.
    2) Driessens FCM, Boltong MG, Bermudez O, Planell JA. Formulation and setting times of some calcium orthophosphate cements: A pilot study. J. Mater. Sci: Mater. Med., 1993, 4, 503–508.
    Books
    Strunk W, Jr, White EB. The Elements of Style 4th ed. Longman, New York, 2000.
    Book Chapters
    Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ (Eds.),Introduction to the Electronic Age. E-Publishing Inc., New York, 2009, pp. 281–304.
    Web references
    As a minimum, the full URL
  • Copyright notice & Permissions: 
    Upon acceptance of an article, authors will be asked to complete a "Copyright notice and permission letter". 
    Dear editor (Drug Invention Today),
    Sub: Submission of an original paper with copyright agreement and authorship responsibility ( submit by e-mail only)
     Topic entitled:
    I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published or is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.
     
    Kindly find it suitable to publish in your esteemed journal.
    Thanking you
    Yours sincerely,
     
                                                                         
    Author name and address                                                             Signature
  • EDITORIAL BOARD 
    Editors:  
    Prof. S. Parial (Pharmacy, Pharmacognosy)
    ·Dr.M.Swaroopa, UGC Post Doctoral Fellow in Biomedicine, Division of Zoology, Sri Padmavati Mahila Visvavidyalayam, Tirupati,A.P,India
    ·Dr. Fengguo Xu,Dept of Epidemiology and Public Health,Yong Loo Lin School of Medicine,National University of Singapore,MD3, 16 Medical Drive, Singapore 117600.
    ·Dr. D. Nagasamy Venketash,Dept of Pharmaceutics,JSS College of Pharmacy,Ooty - 643 001. Tamil Nadu. India.
    ·Dr. Suvardhan Kanchi, Department of Chemistry,Durban University of Technology,Durban,South Africa.
    ·Dr. Zhiyong Peng ,Department of CardioVascular Sciences,Heart Institute,East Carolina University,115 Heart Dr,Greenville, NC 27834,USA.
    ·Dr. Y. K . Gupta, Professor and Head,Dept. of Chemistry,B K Birla Institute of Engineering and Technology,CEERI road,Pilani (Rajasthan), India.
    ·Dr. Bishwambhar Mishra , (Assistant Professor, Dept. of Biotechnology, Sreenidhi Institute of Science and Technology,Hyderabad, India)
    ·Dr. Sat Pal Singh Bisht, ( Professor, Dept of Zoology, Kumaun University, Nainital-263002, Uttarakhand, India )
    ·Dr.Mohamed El Houseiny El Sebeay Shams (Head of the Department of Pharmacy Practice,Oman Pharmacy Institute,Ministry of Health, PO Box 1928, Muscat 114, Oman)
    ·Dr. Smaranika Pattnaik, (School of Life Sciences, Sambalpur University, Burla 768019, Odisha,India)
    ·Dr. Kondawar M. S.Prof. and Head,Department of Quality Assurance,Appasaheb Birnale college of Pharmacy,South Shivajinagar, Sangli-Miraj road,Sangli - 416416 (MS)India.
    ·Dr. Md. Amirul Islam , Pharmacy Discipline,Khulna University,Khulna-9208, Bangladesh
    ·Prof. Vaithiamanithi Perumal,SAIMS Medical College, Indore,India
    ·Dr. Biswa Mohan Sahoo,HOD & Associate Professor,Dept. of Medicinal Chemistry,Vikas College of Pharmacy,,Putrela Road, Vissannapeta, Krishna Dist-521215 ,Andhra Pradesh, India
    ·Dr. Popat Mohite.Associate Professor, Dapartment of Pharmaceutical Chemistry, MES's College of Pharmacy, SonaiTal- Newasa Dist-Ahmednagar, Maharashtra-414105
    ·Dr. Shankar Ananth,India
    ·Dr. Wei Zhang, China
    ·Dr. Goutam Kumar Jana,Department of Pharmacognosy,Gayatri College of Pharmacy,At- Gayatri Vihar, PO- Jamadarpali, Via- Sason,Dist- Sambalpur, Pin- 768200, OrissaIndia
    ·Dr. Asim Ahmad Elnour,UAE
    ·Dr. Geetha Kodali,Mexico
    ·Dr. Syed Haris Omar, Pharmacology,Qassim University,Saudi Arabia
    ·Dr. Jaykaran (Medical Sciences), India
    ·Dr. Vijay Dhondiram Wagh, Pharmaceutical Technology, India
    ·Dr. Ramdas Bhanudas Pandhare, University of Pune, India
    Advisory Board:
    ·Dr. G.S. Lavekar, Former DG, CCRAS – AYUSH (Govt. of India)
    ·Dr. Debasish Bandyopadhyay ( Calcutta University, Kolkata)
    ·Dr. Faiyaz Ahamed, India
    ·Dr. Shete R.V, India
    ·Dr. Ramesh Putheti, United States
    ·Dr. Yuanxiong Deng, China
    ·Dr. Praveen Bansal, India
    ·Dr. C. Rajasekaran, India
    ·Dr. A. K. Meena, (NIAPR, Patiala) India
    · Dr. Jongwha Chang, USA 
    · Dr. Somasekhar Penumajji, South Korea
     
     [ Join the Editorial board by sending brief biodata mail OR Register  in login page : info@jprsolutions.info ]

Recent Manuscripts published

Journal: Drug Invention Today

Title: Development and validation of a RP-HPLC method for quantification of rottlerin in Kamala (Mallotus philppinensis)
Section: Research Article
Category: Drug or Formulation Analysis
Country: India
View Article

Kamala is orange red powder consisting the glands and hair covering the fruit of Mallotus philppinensis Muell. (Euphorbiaceae), a small tree widely distributed throughout India up to an attitude of 1500 m. It is indigenous to southeastern Asia and find wild throughout tropical Asia, Australia and Philippines. In the indigenous system of medicine, Kamala is used as anthelminitic and cathartic. Kamala powder is used in external application for parasitic affection of the skin and also an aphrodisiac, lithotropic, and stypic. Kamala powder is also used as an antiseptic in blisters in the ears. The seed and fruit powder are generally used for urinary and menstrual disorders. A selective, precise and accurate Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method has been developed for the quantification of Rottlerin in kamala. The use of reverse phase C18 column using gradient mobile phase of acetonitrile and water enabled the efficient separation of the chemical markers within a 22 minute analysis. Validation of method performs in order to demonstrate its selectivity, accuracy, precision, repeatability and recovery study. The proposed RP-HPLC method was found to be simple, precise and accurate and can be used for the quality control of the raw materials as well as formulations.

Journal: Drug Invention Today

Title: Antifungal activity of stem bark of Helicteres isora Linn.
Section: Research Article
Category: Microbiological Study (on Natural/ Synthetic drug)
Country: India
View Article

The effect of petroleum ether and methanol extract of stem bark of Helicteres isora was investigated in five different fungus i.e. Cryptococcus neoformans, Candida tropicalis, Trychophyton rubrum, Microsporum furfure, Epidermophyton floccosum to evaluate the antifungal activity. For this evaluation Sabouraud’s glucose broth media was used. All the two extracts exhibited antifungal activity. The methanol extracts showed significant antifungal activity; where as the petroleum ether extract showed weak antifungal activity.

Journal: Drug Invention Today

Title: Antimycotic activity of the componenets of Abutilon indicum (Malvaceae)
Section: Research Article
Category: Pharmacological Screening
Country: India
View Article

The search for novel antifungal agents relies in great part on ethnobotanical information and ethnopharmacologic exploration. Methanol extracts provide a more complete extraction, including less polar compounds, and many of these extracts have been found to possess antifungal properties. Methanolic extracts of various parts of Abutilon indicum were tested for their ability to inhibit the aetiological agents of dermal fungal infections in humans. The screening for the antimycotic activity was performed by testing Minimum Inhibitory concentration and Disc diffusion method. Thin layer chromatographic analysis of plant extract used to purify the flavonoid content of plant parts. Quercetin present in these extracts was separated. Methanolic extract of leaves of Abutilon indicum shows remarkable antifungal activity against Trichophyton rubrum. This study provides a sample large enough to determine the antimycotic properties of A. indicum and suggest further studies for a possible therapeutic use.